Linda de Munck
- Oncology top 5%
- Cancer Research top 2%
- Pathology and Forensic Medicine top 2%
- Surgery top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Sabine SieslingLuc J. A. StrobbePhilip PoortmansMarissa C. van MaarenGeertruida H. de BockThijs van DalenMarjolein L. SmidtSabine C. Linn
- Topics
- Breast Cancer Treatment Studies (48 papers)Global Cancer Incidence and Screening (40 papers)Breast Lesions and Carcinomas (29 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Linda de Munck
76 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 80
- Oncology 980
- Cancer Research 947
- Pathology and Forensic Medicine 470
- Surgery 366
- Pulmonary and Respiratory Medicine 213
Countries citing papers authored by Linda de Munck
This map shows the geographic impact of Linda de Munck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda de Munck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda de Munck more than expected).
Fields of papers citing papers by Linda de Munck
This network shows the impact of papers produced by Linda de Munck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda de Munck. The network helps show where Linda de Munck may publish in the future.
Co-authorship network of co-authors of Linda de Munck
This figure shows the co-authorship network connecting the top 25 collaborators of Linda de Munck. A scholar is included among the top collaborators of Linda de Munck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda de Munck. Linda de Munck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 10 | |
| 7 | 1 | |
| 8 | 6 | |
| 9 | 8 | |
| 10 | 4 | |
| 11 | 7 | |
| 12 | 11 | |
| 13 | 10 | |
| 14 | 25 | |
| 15 | 10 | |
| 16 | 7 | |
| 17 | 12 | |
| 18 | 20 | |
| 19 | 109 | |
| 20 | A phase III study on the efficacy and safety of docetaxel, every three weeks or as a weekly regimen in patients with metastatic breast cancer | 1 |
About Linda de Munck
Linda de Munck is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 79 papers that have together received 1.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (48 papers), Global Cancer Incidence and Screening (40 papers) and Breast Lesions and Carcinomas (29 papers). The work is most often cited by research in Cancer Research (947 citations), Oncology (980 citations) and Pathology and Forensic Medicine (470 citations). Linda de Munck has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Sabine Siesling, Luc J. A. Strobbe, Philip Poortmans, Marissa C. van Maaren, Geertruida H. de Bock, Thijs van Dalen, Marjolein L. Smidt, Sabine C. Linn, Jan J. Jobsen and Pieter J. Westenend. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.